tiprankstipranks
Tharimmune (THAR)
NASDAQ:THAR
US Market

Tharimmune (THAR) Financial Statements

55 Followers

Tharimmune Financial Overview

Tharimmune's market cap is currently ―. The company's EPS TTM is $-104.12; its P/E ratio is -0.04; Tharimmune is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.47M$ -1.82M$ -2.33M$ 2.75M$ -175.44K
EBITDA$ -2.47M-$ -2.33M$ 2.75M$ -175.44K
Net Income Common Stockholders$ -2.47M$ -1.82M$ -2.34M$ 2.74M$ -1.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.94M$ 2.69M$ 3.90M$ 3.57M$ 6.51M
Total Assets$ 10.95M$ 3.17M$ 4.60M$ 4.72M$ 6.69M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -10.94M$ -2.69M$ -3.90M$ -3.57M$ -6.51M
Total Liabilities$ 1.82M$ 1.41M$ 1.53M$ 1.52M$ 1.14M
Stockholders Equity$ 9.13M$ 1.76M$ 3.08M$ 3.20M$ 5.54M
Cash Flow-
Free Cash Flow$ -1.40M-$ -1.51M$ -3.46M$ -1.10M
Operating Cash Flow$ -1.40M$ -924.29K$ -1.51M$ -3.46M$ -1.10M
Investing Cash Flow-----
Financing Cash Flow$ 9.66M$ -306.01K$ 1.85M$ 523.36K$ -22.46K
Currency in USD

Tharimmune Earnings and Revenue History

Tharimmune Debt to Assets

Tharimmune Cash Flow

Tharimmune Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis